EIG
DGX icon

EdgePoint Investment Group’s Quest Diagnostics DGX Stock Holding History

EdgePoint Investment Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$440M Buy
2,243,869
+582,797
+35% +$113M 3.53% 13
2025
Q4 		$288M Buy
1,661,072
+811,320
+95% +$148M 2.37% 15
2025
Q3 		$162M Buy
849,752
+848,481
+66,757% +$151M 1.21% 21
2025
Q2 		$228K Buy
+1,271
New +$221K ﹤0.01% 39

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EdgePoint Investment Group's DGX Position: Q1 2026 in Review

EdgePoint Investment Group increased its Quest Diagnostics (DGX) stake by 35% in Q1 2026, buying an estimated $113M and bringing the position to 2,243,869 shares worth $440M. The position accounts for 3.53% of the portfolio, ranked #13.

EdgePoint Investment Group first reported a position in DGX in Q2 2025 and has held it in 4 quarters since. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • EdgePoint Investment Group held 2,243,869 shares of Quest Diagnostics worth $440M as of Q1 2026.
  • EdgePoint Investment Group bought 582,797 Quest Diagnostics shares in Q1 2026, an estimated $113M.
  • Quest Diagnostics made up 3.53% of EdgePoint Investment Group's portfolio in Q1 2026, its #13 holding.
  • EdgePoint Investment Group first reported a position in Quest Diagnostics in Q2 2025 and has held it in 4 quarters since.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on EdgePoint Investment Group's 13F filing for Q1 2026, filed 15 May 2026.